• Moelis & Company recently reported fourth-quarter and full-year 2025 results that exceeded analyst expectations, while also declaring a regular quarterly dividend of US$0.65 per share payable on March 26, 2026 to holders of record on February 17, 2026.
• Alongside the earnings beat, the firm completed a prior US$196.47 million repurchase program and unveiled a new, open-ended US$300 million buyback authorization, underscoring management’s emphasis on returning capital to shareholders.
• We’ll now look at how Moelis’s earnings beat and new US$300 million repurchase authorization shape the company’s investment narrative.

This technology could replace computers: discover 22 stocks that are working to make quantum computing a reality.

What Is Moelis' Investment Narrative?

To own Moelis, you need to be comfortable with a pure-play advisory firm whose fortunes are closely tied to deal activity, but which is currently pairing that with strong profitability and disciplined capital returns. The latest quarter continued a pattern of solid earnings growth, with full-year net income up to US$233.0 million and margins higher than a year ago, which helps underpin the regular US$0.65 dividend. The new open-ended US$300 million buyback, coming right after completing a US$196.47 million program, adds a fresh short term catalyst by reducing share count and signaling confidence in the business. At the same time, the stock still trades on a richer earnings multiple than many peers, so any slowdown in transactions or fee pressure could weigh more heavily than in the past.

However, there is one risk around Moelis’s valuation and deal-dependence that investors should not ignore. Moelis' shares have been on the rise but are still potentially undervalued by 26%. Find out what it's worth.

Exploring Other Perspectives

With only two fair value views from the Simply Wall St Community, estimates span about US$76.50 to just under US$98.83, underscoring how far opinions can differ. Set that against Moelis’s richer earnings multiple and reliance on robust deal volumes, and it becomes clear why checking a range of perspectives may help you think through how today’s capital returns could interact with tomorrow’s transaction cycle.

Explore 2 other fair value estimates on Moelis - why the stock might be worth just $76.50!

Build Your Own Moelis Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Moelis research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Moelis research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Moelis' overall financial health at a glance.

Seeking Other Investments?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Outshine the giants: these 30 early-stage AI stocks could fund your retirement.
• We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.